Sort   by:  
 Page size 
UnknownAssociation of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression.
Not available
S-EPMC8060834 | biostudies-literature
UnknownEffect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.
Not available
S-EPMC4349346 | biostudies-literature
UnknownCognitive and motor function in long-duration PARKIN-associated Parkinson disease.
Not available
S-EPMC3947132 | biostudies-literature
UnknownNational randomized controlled trial of virtual house calls for Parkinson disease.
Not available
S-EPMC5595275 | biostudies-literature
UnknownEfficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial.
Not available
S-EPMC7737147 | biostudies-literature
UnknownParkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers.
Not available
S-EPMC8857042 | biostudies-literature
UnknownEffect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.
Not available
S-EPMC8441591 | biostudies-literature
UnknownHigher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.
Not available
S-EPMC4366130 | biostudies-literature
UnknownThe recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension.
Not available
S-EPMC5533816 | biostudies-literature
UnknownPenetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry.
Not available
S-EPMC5656509 | biostudies-literature
Sort   by:  
 Page size